Fresenius Medical Care uses cookies on this website to enhance the user experience and provide the best possible service. By continuing to browse the website, you consent to our use of cookies. For details see our privacy policy.
Fresenius Medical Care today announced that the company has extended the end-date under the merger agreement with NxStage Medical, Inc. to account for the interruption of the Federal Trade Commission’s review of the transaction during the recent U.S. government shutdown.
Fresenius Medical Care, the world’s largest provider of dialysis products and services, is still in the process of seeking approval by the U.S. Federal Trade Commission (FTC) for its acquisition of NxStage Medical, Inc. (“NxStage”) and therefore now expects the transaction to close in early 2019.
Credit relations
Read more about our main financing instruments, senior notes and the credit ratings.
